Home > Research Areas > Other Indications > Other Indication
Cat. No. Product name CAS No.
DC9450 (R)-Baclofen

(R)-Baclofen(STX209) is a selective GABAB receptor agonist.

69308-37-8
DCE-016 Chenodeoxycholic acid

>98%,Standard References

474-25-9
DC11919 Arimoclomol Featured

A nontoxic heat shock protein (HSP) coinducer and potentiator of the heat shock response.

289893-25-0
DC11920 Arimoclomol maleate Featured

A nontoxic, orally active heat shock protein (HSP) coinducer and potentiator of the heat shock response.

289893-26-1
DC11515 Azeloprazole

A novel potent proton pump inhibitor that irreversibly inhibits H+,K+-ATPase activity with IC50 of 0.28 uM.

955095-45-1
DC11546 Azeloprazole sodium

A novel potent, orally active proton pump inhibitor that irreversibly inhibits H+,K+-ATPase activity with IC50 of 0.28 uM.

955095-47-3
DC11519 Ceclazepide

A potent, selective cholecystokinin receptor CCK2 antagonist for treatment of gastroesophageal reflux disease (GERD)..

1801749-44-9
DC11688 Avacopan Featured

Avacopan is a potent, selective, orally availale C5aR (CD88) inhibitor with IC50 of 0.1 nM.

1346623-17-3
DC11525 Mocravimod

A synthetic immunosuppressant that functions as a S1P1 receptor agonist.

509092-16-4
DC11512 Acrizanib Featured

Acrizanib(LHA510) is a potent and selective angiogenesis inhibitor and VEGFR‑2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration.

1229453-99-9
DC8606 Alvimopan monohydrate

Alvimopan(LY 246736; ADL 8-2698) is a peripherally acting mu-opioid receptor (PAM-OR, IC50= 1.7 nM) antagonist for accelerating gastrointestinal recovery after surgery.

1383577-62-5
DC8605 Alvimopan dihydrate

Alvimopan(LY 246736; ADL 8-2698) is a peripherally acting mu-opioid receptor (PAM-OR, IC50= 1.7 nM) antagonist for accelerating gastrointestinal recovery after surgery.

170098-38-1
DC11076 Ampreloxetine

Ampreloxetine (TD-9855) is a potent monoamine reuptake inhibitor with pIC50 of 8.0, 8.6 and 6.8 for human NET, SERT, and DAT, respectively.

1227056-84-9
DC9034 Atomoxetine HCl

Atomoxetine Hcl(LY 139603; Tomoxetine Hcl) is a potent and selective noradrenalin re-uptake inhibitor (Ki values are 5, 77 and 1451 nM for inhibition of radioligand binding to human NET, SERT and DAT respectively).

82248-59-7
DC8971 Baclofen

Baclofen is a gamma-amino-butyric acid (GABA) derivative used as a skeletal muscle relaxant.

1134-47-0
DC8895 benzbromaron Featured

Benzbromarone is a highly effective and well tolerated non-competitive inhibitor of xanthine oxidase, used as an uricosuric agent, used in the treatment of gout.

3562-84-3
DC11354 Carteolol (hydrochloride)

Carteolol is an antagonist of β-adrenergic receptors (Kd = 13 nM).

51781-21-6
DC4160 CB-03-01 Featured

CB-03-01 is a steroidal ester, androgen antagonist derived from 11-deoxycortisone, which tightly mimics the profile of an ideal anti-androgen for topical use.

19608-29-8
DC9183 Clomiphene citrate

Clomifene Citrate is a selective estrogen receptor modulator.

50-41-9
DCAPI1091 Conivaptan hydrochloride Featured

Conivaptan(YM 087) is a non-peptide inhibitor of antidiuretic hormone (vasopressin receptor antagonist) with Ki values of 0.48 and 3.04 nM for rat liver V1A receptor and rat kidney V2 receptor respectively.

168626-94-6
DC4132 CP-547632 Featured

CP-547632 is as a potent inhibitor of the VEGFR-2 and basic fibroblast growth factor (FGF) kinases (IC50 11 and 9 nM, respectively).

252003-65-9
DC11082 Danicopan (ACH-4471) Featured

Danicopan (ACH-4471, ACH-0144471) is a highly potent, orally active Factor D inhibitor with Kd of 0.54 nM, inhibits the proteolytic activity of purified Factor D against substrate Factor B in complex with C3b, blocking production of Bb fragment IC50 of 15 nM.

1903768-17-1
DC9116 Dantrolene sodium

Dantrolene sodium is a inhibitor of calcium channel proteins, inhibiting the release of Ca2+ from the sarcoplasm. Dantrolene sodium is a skeletal muscle relaxant which acts by blocking muscle contraction beyond the neuromuscular junction.

14663-23-1
DCAPI1107 Deferasirox (Exjade) Featured

Deferasirox (Exjade)

201530-41-8
DC9604 Desogestrel Featured

Desogestrel(Org-2969) is a third-generation 19-nortestosterone derivative progestogen; is contained in many oral contraceptive preparations, both combined (COCs) to ethinyl-estradiol (EE) or alone in a progestin-only pill (POP).

54024-22-5
DC8485 E-64d(Aloxistatin) Featured

E-64D is an inhibitor of cathepsins B and L; also thought to inhibit calpain,showed a potent activity for COVID-19(SARS-COV-2)with EC50: MERS-COV(1.275),SARS-COV(0.760)

88321-09-9
DC10939 Edasalonexent

Edasalonexent (CAT-1004) is a bifunctional, orally administered small molecule that covalently links 2 compounds known to inhibit NF‐κB, salicylic acid and docosahexaenoic acid (DHA).

1204317-86-1
DC9771 ACU4429,ACU 4429,ACU-4429 Featured

Emixustat hydrochloride strongly inhibits 11-cis-retinol production with IC50 values of 232 ± 3 nM.

1141934-97-5
DC10314 Emixustat

Emixustat, a novel visual cycle modulator, is an inhibitor of the visual cycle isomerase with an IC50 value of 4.4 nM in vitro.

1141777-14-1
DC11433 Vatiquinone

EPI-743 (Vatiquinone,EPI-589) is an orally bioavailable para-benzoquinone for treatment of inherited mitochondrial diseases, an analogue of the antioxidant ubidecarenone.

1213269-98-7
DC9821 Ezutromid Featured

Ezutromid is a novel Small utrophin's translation modulator with EC50 of 0.4 uM .

945531-77-1
DC8912 Fesoterodine fumarate Featured

Fesoterodine Fumarate is an antimuscarinic agent and is rapidly de-esterified to its active metabolite 5-hydroxymethyl tolterodine that is a muscarinic receptor antagonist.

286930-03-8
DC11187 Fonadelpar

Fonadelpar (NPS-005,SJP-0035) is a potent, selective peroxisome proliferator activated receptor δ (PPARδ) agonist for the treatment of corneal disorders..

515138-06-4
DC11394 Fulacimstat(BAY 1142524) Featured

Fulacimstat(BAY 1142524) is a small molecule chymase inhibitor.

1488354-15-9
DC9859 GAL-021 Featured

GAL-021 is a new intravenous BKCa-channel blocker.

1380341-99-0
DC9738 GSK2881078 Featured

GSK2881078 (GSK-2881078 ) is a selective androgen receptor modulator (SARM).

1539314-06-1
DC10007 Ibiglustat(Genz-682452) Featured

Ibiglustat (Genz-682452,SAR402671), is a potent and selective Glucosylceramide synthase inhibitor and ceramide glucosyltransferase inhibitor.

1401090-53-6
DC7430 Obeticholic acid (INT-747) Featured

INT-747(Obeticholic acid; 6-ECDCA) is a potent and selective FXR agonist(EC50=99 nM) endowed with anticholestatic activity.

459789-99-2
DC7172 IOWH-032

iOWH032 is a novel and potent CFTR inhibitor (IC50=1.01 uM) in T84 and CHO-CFTR cell based assays.

1191252-49-9
DC12374 JNJ-10229570 Featured

JNJ-10229570 (JNJ10229570) is a novel potent, selective melanocortin receptor MC1R and MC5R antagonist with binding IC50 of 270 nM and 200 nM, respectively.

524923-88-4
DC10853 LAU159 Featured

LAU159 is a novelα6β3γ2 GABAA receptor inhibitor.

2055050-87-6
DC12386 Leniolisib (CDZ173) Featured

Leniolisib (CDZ173) is a potent and selective PI3Kδ inhibitor currently in phase II/III clinical trials for the treatment of immunodeficiency disorders.

1354690-24-6
DC7633 Ligandrol (VK5211, LGD-4033) Featured

LGD-4033 is a novel selective androgen receptor modulator (SARM)

1165910-22-4
DC9938 Lusutrombopag(S-888711) Featured

Lusutrombopag(S-888711) is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist being developed by Shionogi for chronic liver disease (CLD) patients with thrombocytopenia prior to elective invasive surgery.

1110766-97-6
DC11524 Mavacamten(MYK-461) Featured

Mavacamten(MYK-461)is a small molecule that reduces contractility by decreasing the ATPase activity of the cardiac myosin heavy chain.

1642288-47-8
DC9527 Methylnaltrexone (Bromide) Featured

Methylnaltrexone Bromide is a pheriphally-acting μ-opioid antagonist that acts on the gastrointestinal tract to decrease opioid-induced constipation.

73232-52-7
DC10326 Mozavaptan

Mozavaptan (OPC31260) is a orally effective, nonpeptide vasopressin V2 receptor antagonist with an IC50 of 14 nM.

137975-06-5
DCAPI1342 Nepafenac

Nepafenac

78281-72-8
DC12298 Octreotide acetate (SMS 201-995 (acetate)) Featured

Octreotide acetate, a long-acting synthetic analog of native somatostatin, inhibits growth hormone, glucagon, and insulin more potently.

79517-01-4
DC10299 Olumacostat glasaretil

Olumacostat glasaretil is a small molecule inhibitor of acetyl coenzyme A carboxylase (ACC).

1261491-89-7
DC11044 Omidenepag Isopropyl Featured

Omidenepag Isopropyl (DE-117, OMDI) is the prodrug of Omidenepag, which is a potent, selective agonist human EP2 receptor; demonstrates excellent IOP-lowering activities following ocular administration in ocular normotensive monkeys, Omidenepag Isopropyl (OMDI) is a clinical candidate for the treatment of glaucoma.

1187451-19-9
DC8353 PF-04418948 Featured

PF-04418948 is an orally active, potent, and selective EP2 receptor antagonist (IC50 = 16 nM).

1078166-57-0
DCAPI1305 Pramiracetam

Pramiracetam

68497-62-1
DC9162 Ranolazine HCl Featured

Ranolazine(RS-43285) is an antianginal agent with antiarrhythmic properties that achieves its effects via a novel mechanism of action (inhibition of the late phase of the inward sodium current), without affecting heart rate or blood pressure (BP).

95635-56-6
DC1048 Rapamycin (Sirolimus) Featured

Rapamycin (Sirolimus, AY-22989, WY-090217) is a specific mTOR inhibitor with IC50 of ~0.1 nM. -

53123-88-9
DC8185 Verosudil(AR-12286)

Rho-kinase (ROCK) inhibitor

1414854-42-4
DC10583 RO 5028442 Featured

RO5028442 is a highly potent and selective Brain-Penetrant Vasopressin 1a (V1a) receptor antagonist with Kis of 1 nM (hV1a) and 39 nM (mV1a).

920022-47-5
DC8198 RTA-408(Omaveloxolone) Featured

RTA-408 is a synthetic triterpenoid that potently activates the antioxidative transcription factor Nrf2 and inhibits the proinflammatory transcription factor NF-κB.

1474034-05-3
DC8224 Lifitegrast(SAR 1118) Featured

SAR 1118 is a potent tetrahydroisoquinoline (THIQ)-derived LFA-1/ICAM-1 antagonist for treating dry eye.

1025967-78-5
DC10925 SAR-100842 Featured

SAR-100842 (SAR100842) is a potent, selective, orally available antagonist of the Lysophosphatidic Acid 1 Receptor (LPA1 receptor) with IC50 of 31 nM in β-arrestin assays.

1195941-38-8
DC9600 Senicapoc Featured

Senicapoc(ICA17043) is a potent and selective Gardos channel blocker; blocked Ca(2+)-induced rubidium flux from human RBCs/ inhibited RBC dehydration with IC50s of 11 nM/30 nM, respectively. IC50 value: 11/30 nM [1] Target: Gardos channel in vitro: I

289656-45-7
DCAPI1485 Silodosin Featured

Silodosin(Rapaflo) is an α1-adrenoceptor antagonist with high uroselectivity. Silodosin causes practically no orthostatic hypotension (in contrast to other α1 blockers). Since Silodosin is a highly selective inhibitor of the α1A adrenergic receptor, it ca

160970-54-7
DC8592 Sivelestat (sodium salt hydrate) Featured

Sivelestat(ONO5046; LY544349; EI546) is a competitive inhibitor of human neutrophil elastase(IC50 = 44 nM; Ki=200 nM); also inhibited leukocyte elastase obtained from rabbit, rat, hamster and mouse.

201677-61-4
DC8500 SKQ1(Visomitin) Featured

SKQ1 prevents amyloid-beta-induced impairment of long-term potentiation in rat hippocampal slices.

934826-68-3
DC9732 Sufugolix(TAK-013) Featured

Sufugolix(TAK-013) is a non-peptide, orally-active, selective antagonist of the gonadotropin-releasing hormone receptor (GnRHR) (IC50 = 0.1 and 0.06 nM for affinity and in vitro inhibition, respectively).

308831-61-0
DC11026 Tecovirimat Featured

Tecovirimat (ST-246, Tpoxx) is a potent, orally bioavailable, first-in-class inhibitor of orthopoxvirus egress with EC50 of 0.01-0.6 uM against a panel of Orthopoxviruses; ST-246 is active against multiple orthopoxviruses, including vaccinia, monkeypox, c

869572-92-9
DC9148 Tolvaptan Featured

Tolvaptan is a selective, competitive arginine vasopressin receptor 2 antagonist with an IC50 of 1.28μM for the inhibition of AVP-induced platelet aggregation.

150683-30-0
DC11385 Trofinetide(NNZ2566) Featured

Trofinetide (NNZ-2566) is an analog of a molecule which is derived from IGF-1 and occurs naturally in the brain. IGF-1 is a growth factor stimulated by growth hormone.

853400-76-7
DC9816 Valbenazine(NBI-98854) Featured

Valbenazine(NBI-98854) is a potent and selective VMAT2 inhibitor..

1025504-45-3
DC9187 Mosapride Citrate

Mosapride citrate is a gastroprokinetic agent that acts as a selective 5HT4 agonist.

112885-42-4
Page 1 / Total 1 FirstPrevNextLastGoto